Summary of INTERCEPT PHARMACEUTICALS INC

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

ICPT > SEC Filings for ICPT > Form 8-K on 19-Dec-2012

All Recent SEC Filings

Show all filings for INTERCEPT PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for INTERCEPT PHARMACEUTICALS INC

19-Dec-2012

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On December 19, 2012, Intercept Pharmaceuticals, Inc. issued a press release announcing that it has completed enrollment in POISE, its pivotal Phase 3 clinical trial of obeticholic acid (OCA) in primary biliary cirrhosis (PBC).

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibit is filed with this report:

Exhibit
Number  Description

99.1    Press Release dated December 19, 2012.

The press release contains hypertext links to information on our website and/or other websites. The information contained in or accessible from our website or any other website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K.

Add ICPT to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for ICPT - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.